References
- Peterson KL, Wang M, Canalis RF, et al. Rhinocerebral mucormycosis: evolution of the disease and treatment options. Laryngoscope. 1997;107:855–862.
- Spellberg B, Edwards J Jr., Ibrahim A. Novel perspectives on mucormycosis: pathophysiology, presentation, and management. Clin Microbiol Rev. 2005;18:556–569.
- Turner JH, Soudry E, Nayak JV, et al. Survival outcomes in acute invasive fungal sinusitis: a systematic review and quantitative synthesis of published evidence. Laryngoscope. 2013;123:1112–1118.
- Lee DH, Yoon TM, Lee JK, et al. Invasive fungal sinusitis of the sphenoid sinus. Clin Exp Otorhinolaryngol. 2014;7:181–187.
- Hora JF. Primary Aspergillosis of the paranasal sinuses and associated areas. Laryngoscope. 1965;75:768–773.
- Gillespie MB, O'Malley BW Jr., Francis HW. An approach to fulminant invasive fungal rhinosinusitis in the immunocompromised host. Arch Otolaryngol Head Neck Surg. 1998;124:520–526.
- Piromchai P, Thanaviratananich S. Impact of treatment time on the survival of patients suffering from invasive fungal rhinosinusitis. Clin Med Insights Ear Nose Throat. 2014;7:31–34.
- Saedi B, Sadeghi M, Seilani P. Endoscopic management of rhinocerebral mucormycosis with topical and intravenous amphotericin B. J Laryngol Otol. 2011;125:807–810.
- Kara IO, Tasova Y, Uguz A, et al. Mucormycosis-associated fungal infections in patients with haematologic malignancies. Int J Clin Pract. 2009;63:134–139.
- Pagano L, Valentini CG, Posteraro B, et al. Zygomycosis in Italy: a survey of FIMUA-ECMM (Federazione Italiana di Micopatologia Umana ed Animale and European Confederation of Medical Mycology). J Chemother. 2009;21:322–329.
- Miceli MH, Kauffman CA. Isavuconazole: a new broad-spectrum triazole antifungal agent. Clin Infect Dis. 2015;61:1558–1565.
- Min JY, Tan BK. Risk factors for chronic rhinosinusitis. Curr Opin Allergy Clin Immunol. 2015;15:1–13.
- Zuniga MG, Turner JH. Treatment outcomes in acute invasive fungal rhinosinusitis. Curr Opin Otolaryngol Head Neck Surg. 2014;22:242–248.
- Groppo ER, El-Sayed IH, Aiken AH, et al. Computed tomography and magnetic resonance imaging characteristics of acute invasive fungal sinusitis. Arch Otolaryngol Head Neck Surg. 2011;137:1005–1010.
- Plowes Hernandez O, Prado Calleros HM, Soberon Marmissolle Daguerre GS, et al. Rhino-orbito-cerebral mucormycosis. Management strategies to avoid or limit intracraneal affection and improve survival. Acta Otorrinolaringol Esp. 2015;66:348–352.
- Blitzer A, Lawson W, Meyers BR, et al. Patient survival factors in paranasal sinus mucormycosis. Laryngoscope. 1980;90:635–648.
- Hargrove RN, Wesley RE, Klippenstein KA, et al. Indications for orbital exenteration in mucormycosis. Ophthal Plast Reconstr Surg. 2006;22:286–291.
- Colon-Acevedo B, Kumar J, Richard MJ, et al. The role of adjunctive therapies in the management of invasive sino-orbital infection. Ophthal Plast Reconstr Surg. 2015;31:401–405.
- Marty FM, Ostrosky-Zeichner L, Cornely OA, et al. Isavuconazole treatment for mucormycosis: a single- arm open-label trial and case-control analysis. Lancet Infect Dis. 2016;16:828–837.